Collegium enters $50M accelerated share repurchase with Jefferies

COLLEGIUM PHARMACEUTICAL, INC

ASR agreement with Jefferies LLC to repurchase $50M of common stock, announced Aug 12, 2026.
Initial delivery of 1,556,420 shares at $25.70 closing price (Aug 12, 2026), ~80% of expected total.
Part of $150M buyback program authorized July 2025; final settlement expected by Q4 2026.
Final share count based on VWAP during term; ~32.5M shares outstanding as of June 30, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.